Eu Ivdr Eu Ivd Class B On The Market

IDS Cardiolipin IgG

Devices (same UDI-DI)
1
Certificates
0
Countries
32
Notified Bodies
0

Basic Information

Primary DI
05060169694101
Basic UDI-DI Code
5060169694101WW
Reference
IS-AI1501
Device Types
None provided
Regulation
Eu Ivdr
Classification
Eu Ivd Class B
Status
On The Market

Additional Description

The IDS Cardiolipin IgG test is a chemiluminescent immunoassay (CLIA) for use on the IDS System for quantitative determination of the specific β2-glycoprotein I dependent anti-cardiolipin IgG antibodies in samples of human serum or plasma (EDTA, heparin). Results are to be used in conjunction with other clinical and laboratory data as an aid in the evaluation of antiphospholipid syndrome (APS).

CND Nomenclature Codes

Code Description
W0102100501 ANTI-CARDIOLIPIN ANTIBODIES

Available In Countries

🇦🇹 Austria 🇧🇪 Belgium 🇧🇬 Bulgaria 🇨🇾 Cyprus 🇨🇿 Czechia 🇩🇪 Germany 🇩🇰 Denmark 🇪🇪 Estonia 🇬🇷 Greece 🇪🇸 Spain 🇫🇮 Finland 🇫🇷 France 🇭🇷 Croatia 🇭🇺 Hungary 🇮🇪 Ireland 🇮🇸 Iceland 🇮🇹 Italy 🇱🇮 Liechtenstein 🇱🇹 Lithuania 🇱🇺 Luxembourg 🇱🇻 Latvia 🇲🇹 Malta 🇳🇱 Netherlands 🇳🇴 Norway 🇵🇱 Poland 🇵🇹 Portugal 🇷🇴 Romania 🇸🇪 Sweden 🇸🇮 Slovenia 🇸🇰 Slovakia 🇹🇷 Türkiye 🇬🇧 United Kingdom

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Class B) and regulation (EU IVDR).

View all